JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

115.41

+1%↑

VEEV

160.84

+3.11%↑

Kodu・Aktsiate loetelu・Palvella Therapeutics Inc

P
Palvella Therapeutics Inc

Suletud

SektorTervishoid

122.77 -3.16

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

121.62

Max

123.52

Põhinäitajad
By Trading Economics
Sissetulek	-1.4M -13M
Töötajad	29

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+88.12% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	14. mai 2026

Turustatistika
By TradingEconomics
Turukapital	249M 1.6B
Eelmine avamishind	125.93
Eelmine sulgemishind	122.77

Palvella Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

26. apr 2026, 21:14 UTC

Uudisväärsed sündmused

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

26. apr 2026, 21:14 UTC

Uudisväärsed sündmused

Week Ahead for FX, Bonds: Major Central Bank -2-

24. apr 2026, 19:19 UTC

Omandamised, ülevõtmised, äriostud

Intertek Group Rejects EQT's Revised Offer

26. apr 2026, 23:48 UTC

Market Talk

Nikkei May Rise After U.S. Tech Gains -- Market Talk

26. apr 2026, 23:44 UTC

Tulu

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

26. apr 2026, 23:44 UTC

Tulu

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

26. apr 2026, 23:36 UTC

Market Talk

Uudisväärsed sündmused

Gold Falls Amid Dollar's Strength -- Market Talk

26. apr 2026, 23:33 UTC

Market Talk

Uudisväärsed sündmused

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

26. apr 2026, 05:12 UTC

Tulu

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

26. apr 2026, 05:12 UTC

Tulu

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

26. apr 2026, 05:12 UTC

Tulu

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

26. apr 2026, 05:12 UTC

Tulu

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

24. apr 2026, 23:37 UTC

Omandamised, ülevõtmised, äriostud

Scoring the Cook Era -- Barrons.com

24. apr 2026, 20:51 UTC

Omandamised, ülevõtmised, äriostud

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24. apr 2026, 20:50 UTC

Market Talk

Uudisväärsed sündmused

Financial Services Roundup: Market Talk

24. apr 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

24. apr 2026, 20:39 UTC

Omandamised, ülevõtmised, äriostud

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24. apr 2026, 20:09 UTC

Tulu

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24. apr 2026, 19:48 UTC

Market Talk

Uudisväärsed sündmused

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24. apr 2026, 19:25 UTC

Omandamised, ülevõtmised, äriostud

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24. apr 2026, 19:25 UTC

Omandamised, ülevõtmised, äriostud

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24. apr 2026, 19:22 UTC

Tulu

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24. apr 2026, 19:06 UTC

Tulu

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24. apr 2026, 19:05 UTC

Market Talk

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24. apr 2026, 18:30 UTC

Omandamised, ülevõtmised, äriostud

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24. apr 2026, 18:28 UTC

Omandamised, ülevõtmised, äriostud

Intertek Rejects Revised EQT Offer

24. apr 2026, 18:12 UTC

Market Talk

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24. apr 2026, 18:06 UTC

Market Talk

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24. apr 2026, 17:42 UTC

Tulu

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24. apr 2026, 17:28 UTC

Tulu

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Palvella Therapeutics Inc Prognoos

Hinnasiht

By TipRanks

88.12% tõus

12 kuu keskmine prognoos

Keskmine 232.5 USD 88.12%

Kõrge 270 USD

Madal 209 USD

Põhineb 13 Wall Streeti analüütiku instrumendi Palvella Therapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

13 ratings

Osta

Hoia

Müü

Põhineb 13 analüütiku instrumendi Palvella Therapeutics Inc aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Maksueelne kasum

Müük

Intressikulud võla pealt

Ärikasum

Muud aktsiad sektorist

JNJ

Johnson and Johnson

227.58

↓-1.32%

ABT

Abbott Laboratories

91.21

↓-1.32%

MDT

Medtronic PLC

83.38

↓-0.41%

Agilent Technologies Inc

115.41

↑ +1%

VEEV

Veeva Systems Inc

160.84

↑ +3.11%

P Palvella Therapeutics Inc

Ülevaade

Aktsiahinna muutus

Põhinäitajad

Soovitused

Dividendid

Turustatistika

Palvella Therapeutics Inc Graafik

Seotud uudised

Võrdlus sarnastega

Palvella Therapeutics Inc Prognoos

Hinnasiht

Hinnangu Konsensus

Finantsandmed

Muud aktsiad sektorist

P
Palvella Therapeutics Inc